Provectus Biopharmaceuticals (PVCT) Assets (2010 - 2026)
Provectus Biopharmaceuticals (PVCT) posted Assets of $1.47 million for Q2 2026, up 104.0% from $722,384 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals' Assets came in at $697,502, down 30.7% from FY2024.
- Annual Assets has declined for four consecutive years, though with a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- In prior years, Provectus Biopharmaceuticals' Assets was $1.01 million in FY2024 (-30.5%), $1.45 million in FY2023 (-28.9%), $2.04 million in FY2022 (-42.0%) and $3.51 million in FY2021 (+496.3%).
- The Q2 2026 figure stands as the highest quarterly Assets since Q3 2023.
- On a year-over-year basis, Assets increased in 1 of the last seven quarters, with an average decline of 15.9%.
- The strongest year-over-year quarter for Assets in the past five years was Q4 2021, with growth of 496.3%; the weakest was Q3 2021, with a decline of 55.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 1.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Mn |
| Dec 31, 2025 | 697,502.00 |
| Sep 30, 2025 | 419,904.00 |
| Jun 30, 2025 | 722,384.00 |
| Mar 31, 2025 | 666,257.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 802,033.00 |
| Jun 30, 2024 | 856,427.00 |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.69 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 2.05 Mn |
| Jun 30, 2022 | 2.44 Mn |
| Mar 31, 2022 | 2.76 Mn |
| Dec 31, 2021 | 3.51 Mn |
| Sep 30, 2021 | 600,336.00 |
| Jun 30, 2021 | 466,299.00 |
API Access
Provectus Biopharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();